Literature DB >> 23838911

Local immune response predicts survival in patients with thick (t4) melanomas.

Jessica A Cintolo1, Phyllis Gimotty, Anne Blair, Dupont Guerry, David E Elder, Rachel Hammond, Rosalie Elenitsas, Xiaowei Xu, Douglas Fraker, Lynn M Schuchter, Brian J Czerniecki, Giorgos Karakousis.   

Abstract

BACKGROUND: Tumor infiltrating lymphocytes (TIL) and histological regression in primary melanoma are generally considered indicators of the local immune response but their roles as prognostic factors have been variably reported. We examined the prognostic role of these variables in patients with high risk (T4) primary melanomas in a large series of patients with long-term follow-up.
METHODS: From a prospectively maintained cohort of patients diagnosed between 1971 and 2004, 161 patients were retrospectively identified with primary thick melanomas (>4 mm), no clinical evidence of regional nodal disease (RND) at diagnosis and complete histopathologic data. Univariate and multivariate Cox regression models were performed to identify clinical and histopathologic predictors of disease-specific survival (DSS) and to identify subgroups with differential survival.
RESULTS: Factors significantly associated with decreased DSS by univariate analysis included male gender, age ≥ 60 years, axial anatomic location, presence of ulceration, RND, absence of TIL, and presence of regression. In the final multivariate model, TIL and regression, as interacting variables, and RND status remained significantly associated with DSS. In the presence of TIL, concomitant regression was associated with significantly worse survival (p ≤ 0.0001). In the absence of TIL, there was no effect of regression on survival (p = 0.324).
CONCLUSIONS: Primary TIL and regression status and RND status are independently associated with melanoma-specific survival in patients with T4 melanomas; presence of TIL in the primary melanoma with concomitant radial growth phase regression is associated with a poor prognosis and may reflect an ineffective local regional immune response.

Entities:  

Mesh:

Year:  2013        PMID: 23838911     DOI: 10.1245/s10434-013-3086-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.

Authors:  Edmund K Bartlett; Madalyn G Peters; Anne Blair; Mark S Etherington; David E Elder; Xiaowei G Xu; DuPont Guerry; Michael E Ming; Douglas L Fraker; Brian J Czerniecki; Phyllis A Gimotty; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

Review 2.  The prognostic value of liver tumor T cell infiltrates.

Authors:  Hadi Khan; Venu G Pillarisetty; Steven C Katz
Journal:  J Surg Res       Date:  2014-06-07       Impact factor: 2.192

Review 3.  Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response.

Authors:  Martin C Mihm; James J Mulé
Journal:  Cancer Immunol Res       Date:  2015-08       Impact factor: 11.151

4.  The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions.

Authors:  Linda Titus; Raymond L Barnhill; Jason P Lott; Michael W Piepkorn; David E Elder; Paul D Frederick; Heidi D Nelson; Patricia A Carney; Stevan R Knezevich; Martin A Weinstock; Joann G Elmore
Journal:  Lab Invest       Date:  2016-11-28       Impact factor: 5.662

Review 5.  HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.

Authors:  Tristan A Barnes; Eitan Amir
Journal:  Br J Cancer       Date:  2017-07-13       Impact factor: 7.640

Review 6.  Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis.

Authors:  Qiaofen Fu; Nan Chen; Chunlei Ge; Ruilei Li; Zhen Li; Baozhen Zeng; Chunyan Li; Ying Wang; Yuanbo Xue; Xin Song; Heng Li; Gaofeng Li
Journal:  Oncoimmunology       Date:  2019-04-03       Impact factor: 8.110

7.  Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.

Authors:  Jie Yang; John W Lian; Yen-Po Harvey Chin; Liqin Wang; Anna Lian; George F Murphy; Li Zhou
Journal:  JAMA Netw Open       Date:  2021-09-01

8.  Breslow density is a novel prognostic feature in cutaneous malignant melanoma.

Authors:  Hala Rashed; Katarina Flatman; Mark Bamford; Kah W Teo; Gerald Saldanha
Journal:  Histopathology       Date:  2016-10-10       Impact factor: 5.087

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.